Correlation Between Swiss Re and Novartis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Swiss Re and Novartis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Swiss Re and Novartis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Swiss Re AG and Novartis AG, you can compare the effects of market volatilities on Swiss Re and Novartis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Swiss Re with a short position of Novartis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Swiss Re and Novartis.

Diversification Opportunities for Swiss Re and Novartis

-0.4
  Correlation Coefficient

Very good diversification

The 3 months correlation between Swiss and Novartis is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Swiss Re AG and Novartis AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novartis AG and Swiss Re is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Swiss Re AG are associated (or correlated) with Novartis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novartis AG has no effect on the direction of Swiss Re i.e., Swiss Re and Novartis go up and down completely randomly.

Pair Corralation between Swiss Re and Novartis

Assuming the 90 days trading horizon Swiss Re AG is expected to generate 1.63 times more return on investment than Novartis. However, Swiss Re is 1.63 times more volatile than Novartis AG. It trades about 0.31 of its potential returns per unit of risk. Novartis AG is currently generating about -0.28 per unit of risk. If you would invest  11,185  in Swiss Re AG on August 24, 2024 and sell it today you would earn a total of  1,535  from holding Swiss Re AG or generate 13.72% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Swiss Re AG  vs.  Novartis AG

 Performance 
       Timeline  
Swiss Re AG 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Swiss Re AG are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Swiss Re may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Novartis AG 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novartis AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Swiss Re and Novartis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Swiss Re and Novartis

The main advantage of trading using opposite Swiss Re and Novartis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Swiss Re position performs unexpectedly, Novartis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novartis will offset losses from the drop in Novartis' long position.
The idea behind Swiss Re AG and Novartis AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk